RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 8 analysts with an average price target of $9.55. This is a potential upside of $7.37 (338.07%) from yesterday's end of day stock price of $2.18.

Rocket Pharmaceuticals's activity chart (see below) currently has 187 price targets and 168 ratings on display. The stock rating distribution of RCKT is 70.59% BUY, 11.76% SELL and 17.65% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.22% with an average time for these price targets to be met of 164.16 days.

Highest price target for RCKT is $15, Lowest price target is $3, average price target is $9.55.

Most recent stock forecast was given by RICHARD LAW from GOLDMAN SACHS on 08-Oct-2026. First documented stock forecast 28-Jul-2015.

Currently out of the existing stock ratings of RCKT, 12 are a BUY (70.59%), 2 are a SELL (11.76%), 3 are a HOLD (17.65%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 20-Aug-2025

$4

$1.82 (83.49%)

$3

11 days ago
(08-Oct-2026)

1/8 (12.5%)

$1.37 (52.09%)

78

Buy Since 01-Sep-2026

$11

$8.82 (404.59%)

$11

12 days ago
(07-Oct-2026)

0/3 (0%)

$8.46 (333.07%)

Buy Since 01-Nov-2022

$15

$12.82 (588.07%)

$15

12 days ago
(07-Oct-2026)

0/6 (0%)

$12.46 (490.55%)

Hold Since 24-Jul-2025

$9

$6.82 (312.84%)

1 months 3 days ago
(16-Sep-2026)

0/18 (0%)

$5.52 (158.62%)

Buy Since 18-Nov-2025

$9

4 months 16 days ago
(03-Jun-2026)

0/3 (0%)

$5.55 (160.87%)

Show more analysts

Please expand the browser size to see the chart

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 164 days for the stock forecasts to be reached, with an average price target met ratio of 31.22%.

Which analyst most recently updated their price target on RCKT (Rocket Pharmaceuticals)?

Richard Law

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Richard Law works at GOLDMAN SACHS and has 15 price targets and 9 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu with the highest potential upside of $72.82

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Andrew Tsai with the lowest potential downside of -$0.75
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?